Condition: Kidney Function · Kidney Transplant; Complications · Delayed Graft Function · Sponsor: King Chulalongkorn Memorial Hospital
Furosemide is an old drug that has been used frequently in the postoperative period of kidney transplantation, aiming to achieve adequate urine output. There is no previous study that directly evaluate the urine response to standardized dose of furosemide in the postoperative period. The objective is to measure the urine output after standardized dose of furosemide is delivered, as a biomarker to predict the graft function in perioperative period.
This description comes directly from the study's public registry record.
Suwasin udomkarnjananun, M.D. · 66899679885 · suwasin.u@gmail.com
Always discuss trial participation with your own doctor first.
| King Chulalongkorn Memorial Hospital | Bangkok, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03071536